Most people who have used medications to help them lose weight report making better decisions about food, thinking about it less, and feeling more in control.
Fatty liver or nonalcoholic fatty liver disease (NAFLD) is a disorder in which too much fat builds up in the liver. Nonalcoholic steatohepatitis (NASH) occurs when that extra fat causes inflammation and scarring of the liver. If severe enough, NASH can lead to cirrhosis or liver cancer, potentially requiring a liver transplant. In addition, heart-related deaths are one of the main causes of death for people with NAFLD or NASH.
Studies have found that about 25% of people in the world have NAFLD and 2-6% have NASH.
NAFLD/NASH can affect people of any age, including children. It is more common in people with obesity type 2 diabetes, prediabetes, PCOS, high blood pressure, or high cholesterol. There are no medications currently approved to treat NASH. Several medications are being tested in clinical trials for approval. Doctors can also prescribe medications for conditions associated with a fatty liver, such as diabetes and obesity.
The symptoms of NASH are hard to recognize which is why it is underdiagnosed. Newer noninvasive diagnostic tests, offer a safe examination of the liver compared with a liver biopsy that examines a small piece of the liver.
Noninvasive tests include:
It is possible to stop NASH in the early stages from progressing to severe liver damage or cancer through weight loss. This can be accomplished with lifestyle change by focusing on physical activity and nutrition. Weight loss medications and weight loss surgery can be added when needed.
If you’d like to learn more about permanent weight loss, please feel free to call us or schedule an appointment with Dr. Isaacs using the online booking tool on this website.
You Might Also Enjoy...
Most people who have used medications to help them lose weight report making better decisions about food, thinking about it less, and feeling more in control.
The good news is that the maker of Mounjaro offers a savings card. For patients with commercial drug insurance but no coverage for Mounjaro the saving card will still work. This is different than the savings card for other medications.
The average weight loss for patients who undergo bariatric surgery is around 33% of initial body weight compared to an average weight loss of 10% with anti-obesity medications and 3-5% with a low-calorie diet and lifestyle modification.
The approved indication for tirzepatide is diabetes although studies have found that it is a highly effective weight loss medication. My experience has been that insurance companies will only cover tirzepatide for a diabetes diagnosis and not for obesity.
Fatigue, weight gain, mood swings, poor concentration, memory issues, sweating, heart palpitations – your internet search says these are all symptoms of thyroid disease…but what happens when thyroid blood tests are actually normal?
Tirzepatide (Mounjaro) is a new medication recently approved for the treatment of diabetes. Even though the approved indication is only for diabetes, newly released research has shown that tirzepatide is the most effective weight loss medication ever.